Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
暂无分享，去创建一个
R. Borrows | G. Chusney | V. Papalois | T. Cairns | M. Griffith | A. Mclean | N. Hakim | D. Taube | M. Loucaidou | A. Palmer | A. James | S. Singh | J. Van Tromp | J. Stichbury
[1] P Taylor,et al. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] G. Tydén,et al. Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients. , 1999, British journal of clinical pharmacology.
[3] A. Matas,et al. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. , 1996, Transplantation.
[4] R. Kershner,et al. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. , 1996, Transplantation.
[5] U. Christians,et al. Consensus Document: Therapeutic Monitoring of Tacrolimus (FK‐506) , 1995 .